XML 39 R30.htm IDEA: XBRL DOCUMENT v3.19.1
STOCK OPTION PLAN AND STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 31, 2019
Share-based Payment Arrangement [Abstract]  
Schedule of assumptions for fair value of stock options

In addition, the Company amended 1,500,000 stock options previously granted to the new CEO to extend the expiration date to August 22, 2026. These options were all previously vested.

 

    2018  
Risk-free interest rate     2.22% to 2.3 %
Expected dividend yield     0 %
Volatility factor     217.6% to 219.04 %
Expected life of option     1.71 to 5 years  
Schedule of activity under stock plans

The following table summarizes the Company’s stock option activity during the three months ended March 31, 2019:

 

    Shares     Exercise
Price per
Share
    Weighted
Average
Exercise Price
per Share
 
Outstanding as of December 31, 2018     9,594,000     $ 0.10 – 1.21     $ 0.36  
Granted                  
Exercised                  
Options forfeited/cancelled     100,000       0.10       0.10  
Outstanding as of March 31, 2019     9,494,000     $ 0.10 – 1.21     $ 0.37  

 

The following table summarizes the Company’s stock option activity during the three months ended March 31, 2018:

 

    Shares   Exercise
Price per
Share
    Weighted
Average
Exercise Price
per Share
 
Outstanding as of December 31, 2017     9,594,000     $ 0.10 – 1.21     $ 0.36  
Granted     4,000,000        0.06 – 0.20       0.12  
Exercised                  
Options forfeited/cancelled                  
Outstanding as of March 31, 2018     13,494,000     $ 0.06 – 1.21     $ 0.29  

Schedule of information about stock options vested or expected to vest

The following table summarizes information about stock options that are vested or expected to vest at March 31, 2019:

 

               

Options Outstanding 

                           

Exercisable Options

 
                                                 
 

Exercise

Price

     

Number of Options

     

Weighted Average

Exercise Price

Per Share

     

Weighted Average Remaining Contractual Life (Years)

     

Aggregate Intrinsic

Value

     

Number of Options

     

Weighted Average Exercise Price Per Share

     

Weighted Average Remaining Contractual Life (Years)

     

Aggregate Intrinsic Value

 
$ 0.10       1,500,000     $ 0.10       5.50     $       1,500,000     $ 0.10       5.50     $  
  0.18       934,000       0.18       4.23             934,000       0.18       4.23        
  0.20       2,150,000       0.20       3.12             2,150,000       0.20       3.12        
  0.37       58,000       0.37       3.43             58,000       0.37       3.43        
  0.40       2,000,000       0.40       2.42                   0.40       2.42        
  0.42       63,000       0.42       1.75             63,000       0.42       1.75        
  0.50       310,000       0.50       0.58             310,000       0.50       0.58        
  0.60       2,000,000       0.60       2.42                   0.60       2.42        
  0.69       100,000       0.69       5.00             100,000       0.69       5.00        
  1.21       379,000       1.21       4.78             379,000       1.21       4.78        
$ 0.10-1.21       9,494,000     $ 0.29       3.45     $       5,494,000     $ 0.27       4.22     $  
Schedule of non-vested stock options

The following table sets forth the status of the Company’s non-vested stock options as of March 31, 2019 and December 31, 2018:

 

      Number of
Options
    Weighted-
Average
Grant-Date
Fair Value
 
Non-vested as of December 31, 2018       4,000,000     $ 0.50  
Granted              
Forfeited              
Vested              
Non-vested as of March 31, 2019       4,000,000     $ 0.50